Learn About Hepatic Ischemia

What is the definition of Hepatic Ischemia?

Hepatic ischemia is a condition in which the liver does not get enough blood or oxygen. This causes injury to liver cells.

What are the alternative names for Hepatic Ischemia?

Ischemic hepatitis; Shock liver

What are the causes of Hepatic Ischemia?

Low blood pressure from any condition can lead to hepatic ischemia. Such conditions may include:

  • Abnormal heart rhythms
  • Dehydration
  • Heart failure
  • Infection, especially sepsis
  • Severe bleeding

Other causes may include:

  • Blood clots in the main artery to the liver (hepatic artery) after a liver transplant
  • Inflammation of blood vessels, leading to reduced blood flow (vasculitis)
  • Burns
  • Heat stroke
  • Having a sickle cell crisis
What are the symptoms of Hepatic Ischemia?

The person may have an altered mental status due to reduced blood flow to the brain. Other symptoms may include:

  • Loss of appetite
  • Feeling of general discomfort
  • Discomfort in the right upper quadrant of your abdomen
  • Jaundice

Damage to the liver cells most often does not cause symptoms until it affects liver function.

Blood clots in the liver's main artery may cause abdominal pain.

Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Hepatic Ischemia?

Treatment depends on the cause. Low blood pressure and blood clots must be treated right away.

Who are the top Hepatic Ischemia Local Doctors?
Samer T. Tohme
Elite in Hepatic Ischemia
General Surgery
Elite in Hepatic Ischemia
General Surgery

UPMC Liver Cancer Center

9100 Babcock Boulevard, 
Pittsburgh, PA 
Experience:
16+ years
Languages Spoken:
English, Arabic, French
Accepting New Patients
Offers Telehealth

Samer Tohme is a General Surgeon in Pittsburgh, Pennsylvania. Dr. Tohme has been practicing medicine for over 16 years and is rated as an Elite provider by MediFind in the treatment of Hepatic Ischemia. His top areas of expertise are Hepatic Ischemia, Liver Cancer, Fibrolamellar Carcinoma, Hepatectomy, and Liver Transplant. Dr. Tohme is currently accepting new patients.

Elite in Hepatic Ischemia
Transplant Surgery
Elite in Hepatic Ischemia
Transplant Surgery
200 Ucla Medical Plz Ste 214, 
Los Angeles, CA 
Languages Spoken:
English

Ronald Busuttil is a Transplant Surgeon in Los Angeles, California. Dr. Busuttil is rated as an Elite provider by MediFind in the treatment of Hepatic Ischemia. His top areas of expertise are Hepatic Ischemia, Liver Failure, Hepatitis, Liver Transplant, and Pancreas Transplant.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Hepatic Ischemia
Elite in Hepatic Ischemia
Key Laboratory Of Liver Transplantation, 
Nanjing, CN 

Haoming Zhou practices in Nanjing, China. Zhou is rated as an Elite expert by MediFind in the treatment of Hepatic Ischemia. Their top areas of expertise are Hepatic Ischemia, Non-Alcoholic Fatty Liver Disease, Jaundice, Liver Transplant, and Pancreaticoduodenectomy.

What is the outlook (prognosis) for Hepatic Ischemia?

People generally recover if the illness causing hepatic ischemia can be treated. Death from liver failure due to hepatic ischemia is very rare.

What are the possible complications of Hepatic Ischemia?

Liver failure is a rare, but fatal complication.

When should I contact a medical professional for Hepatic Ischemia?

Contact your health care provider right away if you have persistent weakness or symptoms of shock or dehydration.

How do I prevent Hepatic Ischemia?

Quickly treating the causes of low blood pressure may prevent hepatic ischemia.

What are the latest Hepatic Ischemia Clinical Trials?
Unravelling the Impact of Radiofrecuency in Liver Surgery: the Key to Decrease Local Recurrence? (Study LIVERaTION)

Summary: Radiofrequency devices have been increasingly employed in liver surgery in order to achieve proper hemostasis and this use has become more evident with the implementation of minimal invasive surgery. Due to its well-known efficacy for tumor ablation (i.e. hepatocarcinoma) it use has been extended in some cases to ablate the liver surface after resection in questionable resection. Till date, despit...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Stereotactic Body Radiotherapy With Immunotherapy (Atezolizumab Plus Bevacizumab) in Patients With Advanced HCC and Major Portal Vein Tumour Thrombosis

Summary: Patients with PVTT involvement is a significant healthcare burden as they are present in up to 40% of patients with HCC at diagnosis. These patients exhibit a poorer prognosis compared to patients without PVTT, as a result they were often excluded from existing pivotal clinical trials \[9-11\]. Without management, the median OS in affected patients could be as short as 2 to 4 months. The role of l...

Who are the sources who wrote this article ?

Published Date: May 14, 2024
Published By: Jenifer K. Lehrer, MD, Department of Gastroenterology, Aria - Jefferson Health Torresdale, Jefferson Digestive Diseases Network, Philadelphia, PA. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Korenblat KM. Approach to the patient with jaundice or abnormal liver tests. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 133.

Nery FG, Valla DC. Vascular diseases of the liver. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 11th ed. Philadelphia, PA: Elsevier; 2021:chap 85.